The Cancer-related Bioinformatics Databases

doi:10.13560/j.cnki.biotech.bull.1985.2015.11.010

Abstract

Abstract: Malignant tumor has become one of the major diseases that takes seriously risks to human health. In recent years, the rapid development of high-throughput detection technology has become an important means in cancer research. In this way, the cancer genomics data accumulated rapidly. These data is important for the research of mechanisms of tumor initiation and development. Massive biological data management and mining have become the foundation and an important field in cancer research. This article describes the frequently used bioinformatics databases of human tumors, including comprehensive databases, databases of genomics, transcriptomics, proteomics, epigenetics, etc. Here we sum up the status quo of database development in China and abroad, and discuss the existing problems to assist current research.

Key words: bioinformatics, database, biological big data, tumor, OMICs data

Yang Jian, Cai Haoyang. The Cancer-related Bioinformatics Databases[J]. Biotechnology Bulletin, 2015, 31(11): 89-101.

References

[1]Stratton MR, Campbell PJ, Futreal PA. The cancer genome[J]. Nature, 2009, 458: 719-724.
[2]Benson DA, Clark K, Karsch-Mizrachi I, et al. GenBank[J]. Nucleic Acids Res, 2015, 43(Database issue): D30-35.
[3]Li W, Cowley A, Uludag M, et al. The EMBL-EBI bioinformatics web and programmatic tools framework[J]. Nucleic Acids Res, 2015, 43(W1): W580-584.
[4]Kodama Y, Mashima J, Kosuge T, et al. The DDBJ Japanese Genotype-phenotype Archive for genetic and phenotypic human data[J]. Nucleic Acids Res, 2015, 43(Database issue): D18-22.
[5]Weinstein JN, Collisson EA, Mills GB, et al. The Cancer Genome Atlas Pan-Cancer analysis project[J]. Nat Genet, 2013, 45: 1113-1120.
[6]Hoadley KA, Yau C, Wolf DM, et al. Multiplatform analysis of 12 cancer types reveals molecular classification within and across tissues of origin[J]. Cell, 2014, 158(4): 929-944.
[7]Alexandrov LB, Nik-Zainal S, Wedge DC, et al. Signatures of mutational processes in human cancer[J]. Nature, 2013, 500(7463): 415-421.
[8]Grieb BC, Chen X, Eischen CM. MTBP is overexpressed in triple-negative breast cancer and contributes to its growth and survival[J]. Mol Cancer Res, 2014, 12(9): 1216-1224.
[9]Lappalainen I, Almeida-King J, Kumanduri V, et al. The European Genome-phenome Archive of human data consented for biomedical research[J]. Nat Genet, 2015, 47(7): 692-695.
[10]Wilks C, Cline MS, Weiler E, et al. The Cancer Genomics Hub(CGHub): overcoming cancer through the power of torrential data[J]. Database(Oxford), 2014, 2014. pii: bau093.
[11]International Cancer Genome Consortium. International network of cancer genome projects. [J]. Nature, 2010, 464(7291): 993-998.
[12]Strausberg RL, Buetow KH, Emmert-Buck MR, et al. The cancer genome anatomy project: building an annotated gene index[J]. Trends Genet, 2000, 16(3): 103-106.
[13]Forbes SA, Beare D, Gunasekaran P, et al. COSMIC: exploring the world's knowledge of somatic mutations in human cancer[J]. Nucleic Acids Res, 2015, 43(Database issue): D805-811.
[14]Gao J, Aksoy BA, Dogrusoz U, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal[J]. Sci Signal, 2013, 6(269): pl1.
[15]Goldman M, Craft B, Swatloski T, et al. The UCSC Cancer Genomics Browser: update 2015[J]. Nucleic Acids Res, 2015, 43(Database issue): D812-817.
[16]Zhang J, Finney RP, Rowe W, et al. Systematic analysis of genetic alterations in tumors using Cancer Genome WorkBench(CGWB)[J]. Genome Res, 2007, 17(7): 1111-1117.
[17]Samur MK, Yan Z, Wang X, et al. canEvolve: a web portal for integrative oncogenomics[J]. PLoS One, 2013, 8(2): e56228.
[18]Cai H, Gupta S, Rath P, et al. arrayMap 2014: an updated cancer genome resource. [J]. Nucleic Acids Res, 2015, 43(Database issue): D825-830.
[19]Cao Q, Zhou M, Wang X, et al. CaSNP: a database for interrogating copy number alterations of cancer genome from SNP array data[J]. Nucleic Acids Res, 2011, 39(Database issue): D968-974.
[20]Scheinin I, Myllykangas S, Borze I, et al. CanGEM: mining gene copy number changes in cancer. [J]. Nucleic Acids Res, 2008, 36(Database issue): D830-835.
[21]Timms B. Cancer genome project to start[J]. Eur J Cancer, 2000, 36(6): 687.
[22]Wu TJ, Shamsaddini A, Pan Y, et al. A framework for organizing cancer-related variations from existing databases, publications and NGS data using a High-performance Integrated Virtual Environment(HIVE)[J]. Database(Oxford), 2014, 2014: bau022.
[23]Formosa A, Lena AM, Markert EK, et al. DNA methylation silences miR-132 in prostate cancer[J]. Oncogene, 2013, 32(1): 127-134.
[24]He X, Chang S, Zhang J, et al. MethyCancer: the database of human DNA methylation and cancer[J]. Nucleic Acids Res, 2008, 36(Database issue): D836-841.
[25]Huang WY, Hsu SD, Huang HY, et al. MethHC: a database of DNA methylation and gene expression in human cancer[J]. Nucleic Acids Res, 2015, 43(Database issue): D856-861.
[26]Baek SJ, Yang S, Kang TW, et al. MENT: methylation and expression database of normal and tumor tissues[J]. Gene, 2013, 518(1): 194-200.
[27]Barrett T, Wilhite SE, Ledoux P, et al. NCBI GEO: archive for functional genomics data sets--update[J]. Nucleic Acids Res, 2013, 41(Database issue): D991-995.
[28]Lv J, Liu H, Su J, et al. DiseaseMeth: a human disease methylation database[J]. Nucleic Acids Res, 2012, 40(Database issue): D1030-1035.
[29]Negre V, Grunau C. The MethDB DAS server: adding an epigenetic information layer to the human genome[J]. Epigenetics, 2006, 1(2): 101-105.
[30]Geisen S, Barturen G, Alganza AM, et al. NGSmethDB: an updated genome resource for high quality, single-cytosine resolution methylomes[J]. Nucleic Acids Res, 2014, 42(Database issue): D53-59.
[31]Kolesnikov N, Hastings E, Keays M, et al. ArrayExpress update--simplifying data submissions[J]. Nucleic Acids Res, 2015, 43(Database issue): D1113-1116.
[32]Rhodes DR, Kalyana-Sundaram S, Mahavisno V, et al. Oncomine 3. 0: genes, pathways, and networks in a collection of 18, 000 cancer gene expression profiles[J]. Neoplasia, 2007, 9(2): 166-180.
[33]Wang D, Gu J, Wang T, et al. OncomiRDB: a database for the experimentally verified oncogenic and tumor-suppressive microRNAs[J]. Bioinformatics, 2014, 30(15): 2237-2238.
[34]Xie B, Ding Q, Han H, et al. miRCancer: a microRNA-cancer association database constructed by text mining on literature[J]. Bioinformatics, 2013, 29(5): 638-644.
[35]Bhattacharya A, Ziebarth JD, Cui Y. SomamiR: a database for somatic mutations impacting microRNA function in cancer[J]. Nucleic Acids Res, 2013, 41(Database issue): D977-982.
[36]Frenkel-Morgenstern M, Gorohovski A, Vucenovic D, et al. ChiTaRS 2. 1--an improved database of the chimeric transcripts and RNA-seq data with novel sense-antisense chimeric RNA transcripts[J]. Nucleic Acids Res, 2015, 43(Database issue): D68-75.
[37]Ellis MJ, Gillette M, Carr SA, et al. Connecting genomic alterations to cancer biology with proteomics: the NCI Clinical Proteomic Tumor Analysis Consortium[J]. Cancer Discov, 2013, 3(10): 1108-1112.
[38]He Y, Zhang M, Ju Y, et al. dbDEPC 2. 0: updated database of differentially expressed proteins in human cancers[J]. Nucleic Acids Res, 2012, 40(Database issue): D964-971.
[39]Li J, Duncan DT, Zhang B. CanProVar: a human cancer proteome variation database[J]. Hum Mutat, 2010, 31(3): 219-228.
[40]Tyagi A, Tuknait A, Anand P, et al. CancerPPD: a database of anticancer peptides and proteins[J]. Nucleic Acids Res, 2015, 43(Database issue): D837-843.
[41]Porta-Pardo E, Hrabe T, Godzik A. Cancer3D: understanding cancer mutations through protein structures[J]. Nucleic Acids Res, 2015, 43(Database issue): D968-973.
[42]Cheng WC, Chung IF, Chen CY, et al. DriverDB: an exome sequencing database for cancer driver gene identification[J]. Nucleic Acids Res, 2014, 42(Database issue): D1048-1054.
[43]An O, Pendino V, D'Antonio M, et al. NCG 4. 0: the network of cancer genes in the era of massive mutational screenings of cancer genomes[J]. Database(Oxford), 2014, 2014: bau015.
[44]Leroy B, Fournier JL, Ishioka C, et al. The TP53 website: an integrative resource centre for the TP53 mutation database and TP53 mutant analysis[J]. Nucleic Acids Res, 2013, 41(Database issue): D962-969.
[45]Hamroun D, Kato S, Ishioka C, et al. The UMD TP53 database and website: update and revisions[J]. Hum Mutat, 2006, 27(1): 14-20.
[46]Yang W, Soares J, Greninger P, et al. Genomics of Drug Sensitivity in Cancer(GDSC): a resource for therapeutic biomarker discovery in cancer cells[J]. Nucleic Acids Res, 2013, 41(Database issue): D955-961.
[47]Bulusu KC, Tym JE, Coker EA, et al. canSAR: updated cancer research and drug discovery knowledgebase[J]. Nucleic Acids Res, 2014, 42(Database issue): D1040-1047.
[48]Ahmed J, Meinel T, Dunkel M, et al. CancerResource: a comprehensive database of cancer-relevant proteins and compound interactions supported by experimental knowledge[J]. Nucleic Acids Res, 2011, 39(Database issue): D960-967.
[49]Kumar R, Chaudhary K, Gupta S, et al. CancerDR: cancer drug resistance database[J]. Sci Rep, 2013, 3: 1445.
[50]Pires DE, Blundell TL, Ascher DB. Platinum: a database of experimentally measured effects of mutations on structurally defined protein-ligand complexes[J]. Nucleic Acids Res, 2015, 43(Database issue): D387-391.
[51]李金平, 李宏, 廉斌, 等. 乳腺癌电子数据库的建立及临床应用[J]. 海南医学, 2013, 24(9): 1371-1372.
[52]单华超, 徐海荣, 李远, 等. 原发骨肿瘤流行病学数据库的建立与使用[J]. 中国骨与关节杂志, 2015(9): 693-696.
[53]郑虎, 张红波, 孙彦辉, 等. 脑肿瘤患者认知障碍数据库的初步建立及临床意义[J]. 数理医药学杂志, 2013(4): 410-412.
[54]崔洪亮, 张阳德, 任菲. dbDEMC2. 0: 人类癌症相关miRNA数据库2. 0[J]. 中国现代医学杂志, 2014, 24(3): 77-79.
[55]程卓, 刘珂, 严章明, 等. nc2Cancer: 一个研究与癌症相关人类非编码RNA的数据库[J]. 生物信息学, 2015, 13(2): 77-81.
[56]李孟娇, 鄂琪敏, 刘加林, 等. 喉癌相关基因和miRNA综合数据库的构建[J]. 中华耳鼻咽喉头颈外科杂志, 2015, 50(9): 765-768.